Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015-Reference-Cited by-同舟云学术

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015

Published:2017-04-06 Issue:10 Volume:1 Page:590-600
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Page Evaren E.¹²,Kremer Hovinga Johanna A.³,Terrell Deirdra R.¹,Vesely Sara K.¹,George James N.¹²

Affiliation:

1. Department of Biostatistics and Epidemiology, College of Public Health, and

2. Department of Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK; and

3. Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital and Department of Clinical Research, University of Bern, Bern, Switzerland

Abstract

Key Points The diagnosis of TTP requires clinical judgment in addition to measurement of ADAMTS13 activity. Patients with TTP may not seem to be seriously ill; they may have no or only mild neurologic and kidney function abnormalities.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/1/10/590/877029/advances005124.pdf

Reference31 articles.

1. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura;Furlan;Blood,1997

2. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome;Furlan;N Engl J Med,1998

3. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura;Tsai;N Engl J Med,1998

4. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura;Levy;Nature,2001

5. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients;Vesely;Blood,2003

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial US tertiary health care system experience using caplacizumab in patients with immune thrombotic thrombocytopenic purpura;Annals of Hematology;2024-09-11

2. A Rare Intersection: Managing Thrombotic Thrombocytopenic Purpura in the Context of Dengue Fever;Cureus;2024-09-06

3. The Role of Platelet Levels in Emergency Department Assessment;Eurasian Journal of Critical Care;2024-09-05

4. Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura;Thrombosis Research;2024-09

5. Immune‐mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report;British Journal of Haematology;2024-08-19